Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Prostate. 2012 Apr;72(5):476–486. doi: 10.1002/pros.21450

Table 1.

MAF distribution of resequencing discovered SNPs and indels with regard to dbSNP, 1000 Genome, and HapMap inclusion

SNP Indel Total

Content count MAF
count MAF
count MAF
average (min-max), median average (min-max), median average (min-max), median
dbSNPa 47 0.040 (0.006-0.449), 0.013 5 0.167 (0.029-0.272), 0.217 52 0.052 (0.006-0.449), 0.014
1000 Genomeb 179 0.167 (0.007-0.481), 0.103 18 0.222 (0.019-0.482), 0.130 197 0.172 (0.007-0.482), 0.103
HapMapc 97 0.258 (0.007-0.473), 0.280 0 - - 97 0.258 (0.007-0.473), 0.280
Noveld 103 0.011 (0.006-0.051), 0.008 20 0.076 (0.017-0.278), 0.031 123 0.021 (0.006-0.278), 0.008

Totale 426 43 469 0.137 (0.006-0.482), 0.054
a

dbSNP (b132) reported, exclusive of 1000 Genome or HapMap reported ones

b

1000 Genome CEU (pilot 1 low-coverage data, 10-2010 release) reported, exclusive of HapMap CEU (release 28) reported ones

c

HapMap CEU reported SNPs

d

Novel polymorphisms previously not reported by dbSNP or 1000 Genome CEU data

e

Polymorphism counts and MAF estimation was performed after exclusion of 90 variants with call rate ≤ 40% in 80 (78 PLCO + 2 CEU founders) unrelated Europeans